DRUG · Unmapped registry intervention
Oral Hycamtin (topotecan) Capsules + IV Avastin (bevacizumab)
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
NCT00698516
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Recurrent Small-cell Lung Cancer (SCLC)unresolved
Lung Cancer, Small Cellunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
MemphisTennessee, United States2NashvilleTennessee, United States1SeattleWashington, United States1CincinnatiOhio, United States1MadisonWisconsin, United States1GainesvilleFlorida, United States1Fort WorthTexas, United States1ChattanoogaTennessee, United States1JacksonMississippi, United States1MariettaGeorgia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00698516 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.